InterCure Balans Gezondheid
Financiële gezondheid criteriumcontroles 3/6
InterCure has a total shareholder equity of ₪462.1M and total debt of ₪133.1M, which brings its debt-to-equity ratio to 28.8%. Its total assets and total liabilities are ₪740.9M and ₪278.8M respectively.
Belangrijke informatie
28.8%
Verhouding schuld/eigen vermogen
₪133.07m
Schuld
| Rente dekkingsratio | n/a |
| Contant | ₪20.30m |
| Aandelen | ₪462.12m |
| Totaal verplichtingen | ₪278.77m |
| Totaal activa | ₪740.89m |
Recente financiële gezondheidsupdates
Recent updates
InterCure: A Cannabis Industry Leader Still Flying Under The Radar
Jun 30InterCure: Bargain Israel Cannabis Play
Apr 22InterCure: A Leader In Global Cannabis
Sep 06InterCure reports Q2 results
Aug 15InterCure Is Growing In The Massive Global Cannabis Market
Jun 07IntureCure: Israel Recreation Cannabis Boom On The Way
Feb 16InterCure Chairman Ehud Barak, CEO Alex Rabinovitch - Israel Cannabis And Beyond (Video)
Nov 08InterCure: Internationally Profitable Cannabis (Podcast Transcript)
Sep 19InterCure: Ignored Uplisting
Sep 09Analyse van de financiële positie
Kortlopende schulden: INCR's short term assets (₪370.8M) exceed its short term liabilities (₪208.9M).
Langlopende schulden: INCR's short term assets (₪370.8M) exceed its long term liabilities (₪69.9M).
Schuld/ eigen vermogen geschiedenis en analyse
Schuldniveau: INCR's net debt to equity ratio (24.4%) is considered satisfactory.
Schuld verminderen: INCR's debt to equity ratio has increased from 5% to 28.8% over the past 5 years.
Balans
Analyse van de cashflow
Voor bedrijven die in het verleden gemiddeld verliesgevend zijn geweest, beoordelen we of ze ten minste 1 jaar kasstroom hebben.
Stabiele cash runway: Insufficient data to determine if INCR has enough cash runway based on its current free cash flow.
Voorspelling contante baan: Insufficient data to determine if INCR has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.